Letter: factors that may predict response to ciclosporin in ulcerative colitis - authors' reply

被引：0
|
作者：
Katsuno, T. [1 ]
Saito, K. [1 ]
Yokosuka, O. [1 ]
机构：
[1] Chiba Univ, Dept Med & Clin Oncol K1, Grad Sch Med, Chiba, Japan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 37卷 / 06期
关键词：
FATTY LIVER-DISEASE; APPLICABILITY; DIAGNOSIS; ACCURACY; FIBROSIS; INJURY; BIOPSY;
D O I：
10.1111/apt.12235
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：655 / 655
页数：1
相关论文
共 50 条
  • [41] Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs - a new 'therapeutic package'? Authors' reply
    Norgard, B. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 298 - 299
  • [42] Is cytomegalovirus really a cause of resistance to steroids in ulcerative colitis? The authors reply
    Takahashi, Y
    Tange, T
    DISEASES OF THE COLON & RECTUM, 2005, 48 (01) : 174 - 175
  • [43] Reporting of relapse rates in a trial of mesalazine for ulcerative colitis: authors' reply
    Lichtenstein, G. R.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (09) : 1206 - 1207
  • [44] Editorial: Striving for Equitable Care in Ulcerative Colitis-Authors' Reply
    Mcfalls, Caya
    Melia, Joanna
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (04) : 718 - 718
  • [45] Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis: authors' reply
    Thanaraj, S.
    Hamlin, P. J.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 289 - 289
  • [46] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis-Authors' reply
    Desai, Aakash
    Regueiro, Miguel
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1243 - 1243
  • [47] Letter: persisting clinical symptoms in microscopic colitis in remission - authors' reply
    Nyhlin, N.
    Wickbom, A.
    Montgomery, S. M.
    Tysk, C.
    Bohr, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (01) : 118 - 118
  • [48] Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply
    Jangi, Sushrut
    Yoon, Hyuk
    Dulai, Parambir
    Valasek, Mark
    Boland, Brigid
    Jairath, Vipul
    Feagan, Brian
    Sandborn, William
    Singh, Siddharth
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (08) : 957 - 958
  • [49] Complete Resolution of Mucosal Neutrophils May Predict Nonfatigue in Ulcerative Colitis
    Braat, Henri
    Parikh, Kaushal
    Peppelenbosch, Maikel P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (11) : 2455 - 2456
  • [50] Genetic markers may predict disease behavior in patients with ulcerative colitis
    Roussomoustakaki, M
    Satsangi, J
    Welsh, K
    Louis, E
    Fanning, G
    Targan, S
    Landers, C
    Jewell, DP
    GASTROENTEROLOGY, 1997, 112 (06) : 1845 - 1853
12345